PharmatrophiX — Aided by C2N Diagnostics — Finds That Its Small-Molecule Drug LM11A-31 Blocked the Rise of an Alzheimer's Disease Tau Pathology Biomarker (NCTNCT03069014) - Patient Guide & Enrollment Help